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a  b  s  t  r  a  c  t
Cynara  scolymus  L., Asteraceae,  are  traditionally  used  to treat  dyspepsia.  This  study evaluated  the
hypolipidemic  and  antiatherogenic  effects  of  an  aqueous  extract  prepared  from the  leaves  of  C.  scoly-
mus  in rat’s  model.  Hypercholesterolemic  rats  (1%  cholesterol  and  0.5%  cholic  acid  for 15 days)  were
treated  (0.5  ml/200  g)  with  extract  of  C. scolymus  (150,  300,  or 600  mg/kg  p.o.;  n  = 6) or  simvastatin
(4  mg/kg  p.o.;  n  =  6)  once  per  day  for 30 days  along  with  hypercaloric  diet.  A control  group  (C) was given
water  (0.5 ml/200  g;  n = 6). A high-cholesterol  diet was  maintained  throughout  the  treatment  period.  Rats
treated  with  extract  of  C.  scolymus  (150,  300, or 600  mg/kg)  and  simvastatin  showed  signiﬁcant  decreases
in  serum  levels  of  total  cholesterol  (−46.9%,  −51.9%,  −44%, and −41.9%,  respectively)  and  low-density
lipoprotein-cholesterol  (LDL-C;  −52.1%,  −54.8%,  −51.9%,  and  −46.7%,  respectively),  compared  with  group
C  (p <  0.005).  Biochemical  analyses  revealed  signiﬁcant  decrease  in the  concentration  of  IL-1,  IL-6,  TNF-,holesterol
IFN-,  C-reactive  protein,  oxidized-LDL,  and  antioxidized-LDL  in  rats  treated  with  extract  of C.  scolymus
(150,  300,  or  600  mg/kg).  There  were  no  differences  in  serum  ALT  enzyme  activity  between  the  groups.
Our  results  suggest  that hypolipidemic  and  antiatherogenic  effects  could  be related  with  the  presence  of
polar substances  present  in aqueous  extract  of  C.  scolymus.
©  2015 Sociedade  Brasileira  de  Farmacognosia.  Published  by Elsevier  Editora  Ltda.  All  rights  reserved.ntroduction
Cardiovascular disease (CVD) is the main cause of mortal-
ty in many countries, accounting for 16.7 million deaths each
ear (Dahlof, 2010; Lloyd-Jones, 2010). Among the causes of CVD,
yperlipidemia is characterized by increased serum lipids, predom-
nantly low density lipoprotein cholesterol (LDL-C) triacylglycerols,
nd decreased high density lipoprotein cholesterol (HDL-C) (Raida
t al., 2008).High circulating concentrations of cholesterol, particularly LDL-
, are associated with an increased risk of atherosclerotic CVD
Tabas et al., 2007). Atherosclerosis (AS), hardening (sclerosis) of
∗ Corresponding author.
E-mail: romanwa@unochapeco.edu.br (W.A. Roman Junior).
http://dx.doi.org/10.1016/j.bjp.2015.11.004
102-695X/© 2015 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editorathe arteries (athero), is a slowly progressing, chronic disorder of
the large and medium-sized arteries that occurs when fatty sub-
stances, cholesterol, cellular waste products, calcium and other
substances accumulate as plaques in the walls of the vessels, reduc-
ing blood ﬂow (Hansson, 2005; Kakadiya, 2009; Livingston and
Lynm, 2012). AS is recognized as a subacute inﬂammatory con-
dition of the arterial vessel wall, characterized by the inﬁltration
of macrophages and T-cells, which interact with one another and
with arterial wall cells (Rocha and Libby, 2009; Wildgruber et al.,
2013). Over the course of inﬂammation, various cytokines have
been reported to stimulate the progression of AS, whereas few were
found to potentially aid in AS regression (Packard and Libby, 2008).
Overproduction of reactive oxygen species has been strongly asso-
ciated with the development of oxidation-related conditions, such
as AS and CVD. AS begins with the transmigration of oxidized low-
density lipoproteins (oxLDL) to the intima (subendothelial space),
 Ltda. All rights reserved.
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ausing injury to endothelial cells (Chen et al., 2010; Melo et al.,
011).
Long-term statin treatment reduces the risk of CVD, decreasing
lasma LDL-C and triacylglycerides levels and slowing the progres-
ion of AS (Elis et al., 2011). However, in many patients, treatment
oals cannot be achieved because of contraindications or poor tol-
rance, which hinders adherence to treatment (Huijgen et al., 2010;
jouke et al., 2011). In addition, statins have been associated with an
ncreased risk of developing type 2 diabetes mellitus (Sattar et al.,
010).
The species Cynara scolymus L., Asteraceae, popularly known as
he globe artichoke, is a perennial plant of Mediterranean origin
Aktay et al., 2000). The leaves of C. scolymus are traditionally indi-
ated for the improvement of digestive and urinary tract function
Küskü-Kiraz et al., 2010). Among the main chemical components
re the caffeoylquinic acid derivatives (cynarin, chlorogenic and
affeic acids) and ﬂavonoids (luteolin and apigenin) (Llorach et al.,
002; Wang et al., 2003). Recently, it was reported that serum
holesterol and triacylglyceride levels were decreased in hyperlipi-
emic rats (4% cholesterol and 1% cholic acid supplemented diet
or one month) treated with standardized artichoke leaf extract
Küc¸ ükgergin et al., 2010) and the aqueous extract of C. scolymus
resented hypolipidaemic activity in streptozotocin-induced dia-
etic rats (Heidarian and Sooﬁniya, 2011). Nevertheless, no studies
ave assessed the hypolipidemic effects of the aqueous extract of
. scolymus in rats by mimicking the popular use of the plant and its
elation with the reduction of proinﬂammatory interleukins. To this
nd, the objective of this study was to investigate the hypolipidemic
nd antiatherogenic effects of an aqueous extract of C. scolymus in
ats.
aterial and methods
tandards and chemicals
All chemicals were analytical-reagent grade and the water was
istilled. The chemicals included ethanol (Vetec®, Rio de Janeiro,
razil), 2 N Folin-Ciocalteu reagent, quercetin, aluminum chloride,
,2-diphenyl-1-picrylhydrazyl (DPPH), gallic and ascorbic acids
Sigma-Aldrich®, St. Louis, MO,  USA).
lant material
Leaves of Cynara scolymus L., Asteraceae, were collected in
hapecó (SC), Brazil (S 26◦50′14′ ′/W 52◦59′12′ ′). The plant samples
ere authenticated by Camila Kissmann, curator of the Herbar-
um of Chapecó Region Community University, where a voucher
pecimen (# 3350) was deposited.
reparation of aqueous extract of Cynara scolymus
A sample of dried leaves of C. scolymus (50 g) of the same par-
icle size was collected by passage through a mesh (425 m;  35
yler/Mesch). The sample was extracted by decoction with water
1000 ml)  for 15 min  (Farmacopeia Brasileira, 2015). The aqueous
xtract of C. scolymus (CS) was concentrated to dryness under
educed pressure at 40 ◦C, then freeze dried and stored at −20 ◦C.
hytochemical analyses
etermination of total phenolic contentTotal phenolics were determined using the Folin-Ciocalteu
ethod (Gutﬁnger, 1981). In brief, the reaction mixture was com-
osed of 0.5 ml  of CS (1 mg/ml), 5 ml  of distilled water, and 0.5 mlrmacognosia 26 (2016) 233–239
of the Folin-Ciocalteu reagent. After a period of 3 min, 1 ml  of sat-
urated sodium carbonate solution (20%) was added. The samples
were vortexed and allowed to stand for 1 h. A standard calibra-
tion curve of gallic acid was  prepared (0.045x  + 0.016, r = 0.999). The
absorbance of blue-colored mixtures was  measured at 725 nm.  Val-
ues were reported as the means of triplicate experiments expressed
as gallic acid (GA) equivalents (mg  gallic acid/g dry extract).
Determination of total ﬂavonoids
Total ﬂavonoid content was determined according to Jay et al.
(1975) with some modiﬁcations. Brieﬂy, 0.5 ml  of 2% aluminum
chloride (AlCl3) in ethanol was mixed with an equal volume of
CS (1 mg/ml). Absorbance readings were taken at 415 nm after 1 h
using ethanol as a blank. Total ﬂavonoid content was  determined
using a standard quercetin curve (y = 0.004x + 0.029, r = 0.999) and
the results were reported as the means of triplicate analyses
expressed as quercetin equivalents (mg quercetin/g of dry extract).
In vitro 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging
assay
Free-radical scavenging activity of the vegetal sample was
measured using the method described by Brand-Williams et al.
(1995) with some modiﬁcations. CS (1 ml) (1–150 g/ml) was
added to 2 ml  of a solution of DPPH radicals in ethanol (0.004%).
The mixture was  vigorously shaken and allowed to stand for
30 min  at room temperature (RT). The absorbance (Asample) of
the resulting solution was measured at 517 nm and the percent
antioxidant activity (AA%) was calculated using the following for-
mula: AA% = 100 − {[(Asample − Ablank) × 100]/Acontrol}. A solution of
ethanol (2 ml)  and CS (1 ml)  was used as the blank (Ablank). A solu-
tion of DPPH (2 ml)  and ethanol (1 ml)  was  used as the control
(Acontrol). Ascorbic and gallic acids and quercetin were used as stan-
dards at the same concentrations as CS. Free radical-scavenging
activity was expressed as the quantity of antioxidants necessary
to decrease the initial DPPH absorbance by 50% (IC50). The IC50
value, which is deﬁned as the amount of CS needed to scavenge
50% of DPPH radicals, was determined using non-linear regression
of percent inhibition against CS concentration.
Animals
The International Guidelines for Care and Use of Laboratory
Animals were followed for all experiments, and the experimen-
tal protocol was approved by the Ethics Committee on Animal Use
(# 092/PGA/11) of the Integrated Regional University, Brazil. Male
Wistar rats (n = 36) weighing 250–275 g were used in the study. The
animals were housed in wire-bottomed 17 cm × 33.5 cm × 40.5 cm
cages in a controlled environment at 22 ± 2 ◦C with a 12 h light-dark
cycle (lights on at 7 am and off at 7 pm)  and minimal noise. The rats
were given ad libitum access to water and commercially prepared
chow pellets (Nuvilab® CR-1, Curitiba, Paraná, Brazil) for rodents.
Hyperlipidemic diet
A standard chow diet [composition (w/w): 48.3% carbohydrate,
23.5% crude protein, 5.9% crude fat, 5.9% crude ash, and 3.9% crude
ﬁber Nuvilab® CR-1] was  triturated in mill (Tecnal® 650/1) and
mixed with cholic acid and cholesterol (989.9:10:0.1). The mix-
ture was moistened, pelleted and dried at greenhouse (Marconi®
MAO35/5) (40 ◦C per 24 h).
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xperimental design
Following a period of acclimatization (15 days), six animals
ere randomly designated as the normal group (N); these ani-
als received food and water ad libitum for the duration of the
xperiment. Another group of animals (n = 30) received a hyper-
holesterolemic diet (chow pellets for rodents) comprising 1%
holesterol and 0.1% cholic acid (Sigma-Aldrich®, St. Louis, MO,
SA). After two weeks under these conditions, the animals were
andomly divided into ﬁve groups of six animals each (n = 6) and
hen treated orally for 4 weeks as follows: group C (negative con-
rol) received 0.5 ml  of distilled water; groups CS 150, 300, and 600
eceived CS at doses of 150, 300, or 600 mg/kg, respectively; group
IMV received 4 mg/kg simvastatin powder (Sigma-Aldrich®, St.
ouis, MO,  USA) as a positive control. The high cholesterol diet was
ontinued throughout the 30-day treatment period. Doses of CS and
imvastatin were based on previous studies (Pankaj et al., 2010).
ll drugs were given as 0.5 ml/200 g body weight diluted with dis-
illed water (in established doses) and subjected to ultrasonication
20 ◦C) to facilitate solubility (Vilkhu et al., 2008; Patel et al., 2012).
t the end of the experimental period, the animals were fasted
or 12 h and anesthetized using a mixture of ketamine (Ketalar;
ﬁzer®, New York, NY, USA) and xylazine (Bayer® AG, Leverkusen,
ermany) (75 mg/kg and 10 mg/kg of body weight, respectively).
lood aliquots were collected for biochemical analyses via cardiac
uncture and the animals were then euthanized with an overdose
f anesthetic.
iochemical analysis of blood samples for markers of
nﬂammation and atherosclerosis
Upon collection, blood samples were immediately centrifuged
t 3000 × g for 15 min. Serum TC, HDL-C, IL-1 (sensitivity: 2 pg/ml;
ange: 1–50 pg/ml), IL-6 (sensitivity: 2 pg/ml; range: 2–200 pg/ml),
NF- (sensitivity: 4 pg/ml; range: 4–500 pg/ml), IFN- (sensitiv-
ty: 4 pg/ml; range: 4–200 pg/ml), IL-10 (sensitivity: 2 pg/ml; range:
–80 pg/ml), CRP, oxLDL, antioxLDL and ALT levels were deter-
ined by enzymatic colorimetric and immunological methods
UV/Vis) using commercial Labtest® kits according to the manu-
acturer’s instructions. A semi-automated analyzer (BioSystems®,
odel BTS 310) was used for all analysis (Li et al., 2012).
erum LDL-C levels were calculated using the Friedewald equation
Friedewald, 1972): LDL-C = TC – [HDL-C – (TG/5)].
tatistical analysis
All results shown are presented as mean values ± standard devi-
tion (SD). The normal distribution of the data was conﬁrmed by
olmogorov–Smirnov and Levene tests, and results analyzed using
ne-way ANOVA followed by Tukey’s post-test using SPSS 20. A
-value of <0.5 was considered statistically signiﬁcant.
esults
hemical constituents of aqueous extract of Cynara scolymus
The total phenolic content (expressed as gallic acid equivalents)
as found to be approximately 359 ± 2.8 mg  (mean ± SD) per gram
f CS, while total ﬂavonoid content (recorded in quercetin equiva-
ents) was approximately 48.07 ± 2.8 mg  (mean ± SD) per gram of
S.etermination of DPPH radical scavenging activity
CS showed in vitro antioxidant activity by the DPPH method
Fig. 1). The highest scavenging effect was observed for CS withFig. 1. 2,2-Diphenyl-1-picrylhydrazyl (DPPH) radical scavenger activity of aqueous
extract from Cynara scolymus (CS), compared with standards ascorbic and gallic acids
and  quercetin. Results are expressed as means ± SD (n = 3).
an IC5057.43 ± 2.05 g/ml, although it showed lower scavenging
abilities than quercetin, ascorbic and gallic acids, which were
used as standards (28.04 ± 1.46, 15.02 ± 1.45 and 3.12 ± 1.34 g/ml,
respectively).
Effects of aqueous extracts of Cynara scolymus on serum lipid
proﬁles
At the end of the four-week treatment, group C exhibited higher
serum levels of TC and LDL-C, compared to group N (p < 0.0001).
All hyperlipidemic rats treated with CS (150, 300, or 600), or sim-
vastatin (SIMV) exhibited signiﬁcant and accentuated decreases in
TC (−46.9%, −51.9%, −44%, and −41.9%, respectively) (Fig. 2A) andFig. 2. Effect of aqueous extract from Cynara scolymus (CS; 150, 300, and 600 mg/kg),
and simvastatin (SIMV; 4 mg/kg) on TC (A) and LDL-C (B), in rats fed a high-fat diet.
Rats were either given a normal diet (N) or the following treatment with water (C).
Values are expressed as means ± SD (n = 6). One way ANOVA *p < 0.0001 compared
with group N. #p < 0.005 compared with group C.
236 R. Mocelin et al. / Revista Brasileira de Fa
Table  1
Effect of aqueous extract from Cynara scolymus (CS; 150, 300, and 600 mg/kg), and
simvastatin (SIMV; 4 mg/kg) on HDL-C, TG and VLDL, in rats fed a high-fat diet. Rats
were either given a normal diet (N) or the following treatment with water (C). Values
are  expressed as means ± SD (n = 6).
Groups HDL-C (mg/dl) TG (mg/dl) VLDL (mg/dl)
N 16.14 ± 9.63 65.15 ± 16.92 13.01 ± 7.85
C  42.11 ± 8.61 204.26 ± 38.23 42.85 ± 7.91
CS  150 27.83 ± 6.27 128.35 ± 39.65 25.66 ± 9.72
CS  300 20.48 ± 12.98 127.65 ± 38.85 25.52 ± 9.43
n
T
b
s
The concentrations of oxLDL (Fig. 4A) and antioxLDL (Fig. 4B)
F
a
wCS  600 27.01 ± 7.13 128.42 ± 40.12 24.95 ± 9.96
SIMV 26.57 ± 8.84 135.23 ± 31.85 26.82 ± 8.11
ot show). There were no differences in the serum levels of HDL-C,
G and very low-density lipoprotein cholesterol (VLDL-C) (Table 1)
etween the groups, as well as, to ALT enzyme activity (data not
how).
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Markers of atherosclerosis
The analysis of proinﬂammatory interleukins revealed a
signiﬁcant decrease in IL-1 (F(5,35) = 44.16; p < 0.0001), IL-6
(F(5,35) = 13.27; p < 0.0001), TNF- (F(5,35) = 8.51; p < 0.0001), and
IFN- (F(5,35) = 10.20; p < 0.0001) concentrations following all treat-
ments (CS 150, CS 300, CS 600 and SIMV) compared with group
C (Fig. 3A–D, respectively). Conversely, group N and all other
treatment groups (CS 150, CS 300, CS 600 and SIMV) exhibited
higher levels of anti-inﬂammatory IL-10 compared with group
C (F(5,35) = 138.20; p < 0.0001) (Fig. 3E). CRP levels were reduced
with CS 150, SC 300, SC 600 and SIMV compared with group C
(F(5,35) = 17.18; p < 0.0001) (Fig. 3F).decreased with all treatments (CS 150, SC 300, SC 600 and
SIMV), compared with group C (F(5,35) = 48.89 and F(5,35) = 621.70;
p < 0.0001, respectively). The highest reductions were observed
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Fig. 4. Effect of aqueous extract from Cynara scolymus (CS; 150, 300, and 600 mg/kg),
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p  < 0.0001 compared with group N. #p < 0.005 compared with group C.
n group SC 600 with results very similar to the SIMV and N
roups.
iscussion
It is well established that elevated blood lipid levels constitute
 major risk factor for atherosclerosis (Keevil et al., 2007; Ascunce
t al., 2012). The search for new drugs capable of reducing these
olecular species and/or regulating their metabolism has gained
omentum over the years, resulting in various reports on signiﬁ-
ant activities of natural products (Jahromi et al., 1993; Meng et al.,
014). To the best of our knowledge, this is the ﬁrst report on the
ypolipidemic and antiatherogenic effects of an aqueous extract
f C. scolymus in cholesterol-fed rats. The results of the present
tudy show that a cholesterol-enriched diet causes an increase in
erum TC and LDL-C levels, which can be mitigated by CS at dosages
anging from 150 to 600 mg/kg. The elevated values of polyphe-
ols and ﬂavonoids revealed in CS, are possibly related to the
ypolipidemic effects that were observed. In a similar study by Bok
t al. (1999), these compounds decreased the enzyme activities of
-hydroxy-3-methyl-glutaryl-CoA (HMG-CoA reductase) and acyl-
oAacetyltransferase in cholesterol-fed rats, thereby decreasing
he levels of cholesterol esters available to form very low den-
ity lipoproteins (VLDL), resulting in reduced VLDL secretion by the
iver. It is known that quercetin can reduce the activities and mRNA
evels of several enzymes involved in the synthesis of fatty acids
Odbayar et al., 2006).The high antioxidant activity of CS probably contributed to its
ipid-lowering effect, as has been reported by Küskü-Kiraz et al.
2010). Studies indicate that C. scolymus possesses antioxidant and
ypocholesterolemic properties. These properties operate throughrmacognosia 26 (2016) 233–239 237
inhibition of LDL oxidation, increased cholesterol elimination in
bile secretions, and reduced cholesterol synthesis via inhibition
of HMG-CoA reductase (Kraft, 1997). Thus, similar effects may
have occurred with CS, contributing to the hypolipidemic activity
observed in cholesterol-fed rats.
Preclinical observations have demonstrated that hypercholes-
terolemia stimulates the accumulation of oxLDL in the arterial
wall, promoting endothelial cell dysfunction and the development
of atherosclerosis (Aikawa and Libby, 2004). Atherosclerosis is a
progressive disease involving both large and medium-sized vessel
walls. It is a common factor in cardiac disorders, but can also affect
other organs (Auger et al., 2005). The importance of inﬂammation in
all stages of atherosclerosis is well established (Libby, 2002). Vari-
ous proinﬂammatory risk factors involving reactive oxygen species
can trigger the production of proinﬂammatory cytokines by NF-
B, which contributes to the development and progression of the
disease (Winther et al., 2005; Vallejo et al., 2014). Other markers
of atherosclerosis include cytokines that are mainly involved in
the early stages of inﬂammation, such asIL-1, IL-6, and TNF-, in
addition to CRP (Vaddi et al., 1994; Ridker et al., 2002; Tzoulaki
et al., 2005; Larsson et al., 2005). Ampliﬁcation of the inﬂamma-
tory response via activation of macrophages is performed by IFN-
(Groyer et al., 2006). In this experiment, the group fed a hyper-
caloric diet and treated with water (C) had higher concentrations
of proinﬂammatory interleukins and treatment with all concentra-
tions of CS (150, 300, and 600 mg/kg) decreased these levels. Similar
results were found by Li et al. (2012) whose proposed mechanisms
to explain these activities highlighted the inactivation of transcrip-
tion factors, STAT1 and NF-B, which are known to precipitate the
inﬂammatory process, by polyphenols (Valerio and Awad, 2011).
Nevertheless, inﬂammatory processes appear to be regulated by
anti-inﬂammatory cytokines, such as IL-10. The regulatory role of
IL-10 was demonstrated by its expression in certain atherosclerotic
lesions, as well as the observation that exogenous IL-10 inhibited
the release of IL-12-induced LDL. This cytokine can inhibit the
action of NF-B, with consequent decreases in proinﬂammatory
cytokine production, inhibition of macrophage apoptosis, expres-
sion of tissue factor and ﬁbrinogen, and proliferation of smooth
muscle cells (Heeschen et al., 2003; Zimmerman et al., 2004; Almer
et al., 2013). As the control group (C) showed very low levels of
this cytokine compared to CS treatments, it can be concluded that
the tested substances may  have contributed to tissue protection of
NF-B.
Increased LDL-cholesterol levels promote deposition of these
particles into arteries with increase in the concentration of reactive
species, reduction in the antioxidant defense systems and sub-
sequent oxidation and formation of oxLDL. These substances are
toxic to endothelial cells, resulting in lesions that stimulate mono-
cytes and macrophages to become foam cells, eventually leading to
atheroma (Groyer et al., 2006; Afonso et al., 2013). In this study, all
evaluated substances decreased oxLDL levels compared to group
C. One hypothesis for this biological activity is that polyphenolic
compounds present in the aqueous extracts of C. scolymus revealed
antioxidant effects, protective properties and decreased oxidative
stress as observed in rat hepatocytes by Gebhardt (1997). These
results are in agreement with those obtained by Fuhrman et al.
(2000) evaluating the effect of the ethanol extract of Zingiber ofﬁc-
inale Roscoe. It was also observed that all groups treated with
aqueous extract of C. scolymus showed reduced levels of autoan-
tibodies against oxLDL compared to group C. According to Young
and McEneny (2001), and Dai et al. (2013) high levels of these anti-
bodies are biochemical indicators of the risk of metabolic syndrome
and are related to atherosclerosis progression.
It is well-known that polyphenolic compounds exhibit var-
ious pharmacological activities, including hypolipidemic and
antiatherogenic effects (Harnaﬁ et al., 2008; Schneider et al., 2015).
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he results of this study are in agreement with Hyun-Soo et al.
2014), indicating that the function of the aqueous extracts of C.
colymus in cholesterol fed-rats is correlated with the decrease of
DL levels, inhibition of a series of proinﬂammatory cytokines, and
ikely the antioxidant effects of polyphenols which could contribute
n the prevention of atherosclerosis. Levels of ALT did not differ
etween treatments groups, indicating the absence of CS toxic-
ty at the doses tested. In this context, CS extract could be helpful
s dietary supplement to prevent or reduce atherosclerosis which
ould reduce treatment costs.
onclusions
Polyphenolic substances present in the aqueous extract of
. scolymus L. “artichoke,” may  be effective in the prevention
f hypercholesterolemia, possibly conferring protection against
therosclerosis.
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